Sunday, October 25, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Regulatoryrfk jrfdagray marketpolicy

RFK Jr. says Americans will buy risky peptides regardless

The health secretary's remarks frame consumer demand as a reason to rethink how the gray peptide market is policed.

DO
By Daniel Okafor · Regulatory Correspondent
Oct 21 10:20 ETSource: Rolling Out

The wire

  1. 01Reporting on comments from RFK Jr. arguing that Americans will purchase peptides even when the products carry safety risk.
  2. 02Telehealth operators, compounders and clinicians watching federal posture on research-peptide enforcement will read this as a signal on tolerance for the gray market.
  3. 03No regulation or agency action accompanies the remarks; it remains political commentary rather than a change in FDA or DEA policy.

From the source

Why RFK Jr. says Americans will buy risky peptides anyway

Read at rollingout.com
PeptiPrescribed peptides from $99/moSee all →